Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.
about
Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitroControl of ovulation in mice by progesterone receptor-regulated gene networksPeroxisome Proliferator-Activated Receptors in Female Reproduction and FertilityInsulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycleThe Deep Correlation between Energy Metabolism and Reproduction: A View on the Effects of Nutrition for Women FertilityFunctions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic DisordersPrenatal exposure to di-(2-ethylhexyl) phthalate (DEHP) affects reproductive outcomes in female miceActivation of Penile Proadipogenic Peroxisome Proliferator-Activated Receptor gamma with an Estrogen: Interaction with Estrogen Receptor Alpha during Postnatal DevelopmentDirect rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells.Peroxisome proliferator-activated receptor-gamma mediates bisphenol A inhibition of FSH-stimulated IGF-1, aromatase, and estradiol in human granulosa cells.Possible role of PPARγ in the negative regulation of ovulatory cascade and luteal development in rats.Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure.hCG-induced down-regulation of PPARγ and liver X receptors promotes periovulatory progesterone synthesis by macaque granulosa cells.Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology.Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS).Pioglitazone treatment decreases follicular fluid levels of tumor necrosis factor-α and interleukin-6 in patients with polycystic ovary syndromeExpression Levels of PPARγ and CYP-19 in Polycystic Ovarian Syndrome Primary Granulosa Cells: Influence of ω-3 Fatty AcidTributyltin increases the expression of apoptosis- and adipogenesis-related genes in rat ovaries.A meta-analysis on the association between PPAR-γ Pro12Ala polymorphism and polycystic ovary syndromeThe effects of old, new and emerging medicines on metabolic aberrations in PCOS.The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARγ-dependent PTEN expression.Role of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovaryPPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.Peroxisome proliferator-activated receptor gamma is a target of progesterone regulation in the preovulatory follicles and controls ovulation in mice.The role of peroxisome proliferator-activated receptors in the development and physiology of gametes and preimplantation embryosPPARs and RXRs in Male and Female Fertility and Reproduction.PPARs and Female Reproduction: Evidence from Genetically Manipulated Mice.Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovariesThe Potential Applications of Peroxisome Proliferator-Activated Receptor delta Ligands in Assisted Reproductive TechnologyThe Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products.Activation of PPARγ by Rosiglitazone does not negatively impact male sex steroid hormones in diabetic rats.Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeysReduced quality and accelerated follicle loss with female reproductive aging - does decline in theca dehydroepiandrosterone (DHEA) underlie the problem?Initiation of the expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in the rat ovary and the role of FSH.The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development.Derivation and Evaluation of Putative Adverse Outcome Pathways for the Effects of Cyclooxygenase Inhibitors on Reproductive Processes in Female Fish.A forum for a highly important and ever-expanding field of studyPPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.Expression of the genes for peroxisome proliferator-activated receptor-γ, cyclooxygenase-2, and proinflammatory cytokines in granulosa cells from women with polycystic ovary syndrome.
P2860
Q24608491-377D09BF-0986-4FBA-85D8-7BA0BFF90C68Q24657461-C5CB0557-1189-4808-B003-AE48E392694AQ26738962-AB5C313A-D9EB-460E-9DDC-EE248857A2EEQ26745509-F4A6AF42-F6D6-44AD-B7DB-BE36C6FF9A45Q26766160-3B6CD747-06B6-4F3D-B5BD-81C09F8B6EB5Q28082264-1D6CD49C-DDB0-4816-95B5-2EC33301DBDCQ28395788-791869C7-8DD2-443A-AF38-6B08E239DB79Q28580476-B56AF703-C67C-414A-93D5-152BB0713F72Q33555875-77B8B99A-B218-4538-A3B1-4775D594C7AEQ33789946-83BF97C5-9486-42F3-A4A6-BAC832CF9AF7Q33844072-F7771ED7-1CBD-48FD-B19C-E22CEE9410CFQ34289032-0FFC9315-E1CA-4C99-B672-EEDB518B71E7Q34392590-0B2AFAD8-9C0E-4109-824D-9134FDBB7916Q34633614-522C34DF-3004-4D1C-926D-75D431D4FFEEQ35249254-9BFB40E7-03D6-4097-A069-4E5E216DD890Q35606054-C3EF07B4-0A21-448D-8E76-BA360BC1B0ACQ35767762-0589BEE6-8DBF-4E1B-B9C0-60B1DB7304F3Q35898949-64DDB213-5936-4FE8-83BC-96ACB0EF05D2Q35925809-3A756DC7-930F-446B-88C8-3E6F2EAD7528Q36106431-3F4B9E8E-AC6D-4D6D-AF1F-65AFF44C9AA9Q36328060-12602407-121C-4AEA-A745-C8D3EB5E52B4Q36379508-679F56FE-AC66-4442-AA1C-B6E39AA8A5BCQ36426752-16190B14-8F6A-42D8-92AE-0B8F0AD15F33Q36465006-01445F3E-1179-4817-8075-630BD49D11C9Q36483442-B0337D6B-7778-458C-9572-4505F0318C26Q36494472-35E109D9-B03C-4643-B75C-05E9B3E1F266Q36528626-850F9141-5999-45CA-9F66-160F5A9DC82EQ36528934-51F6EB5E-D472-4DA9-A604-EE97C42A7785Q36767559-FEC84CF4-B157-4E53-AA00-23B18833BDCAQ37015993-4C6003E9-50F4-4378-9887-864C2382E22FQ37211832-D29EAA94-1575-4A78-A83B-C4D9F44CDA07Q37226962-37D48FF7-0B0A-46C7-A514-EFC5614CDA7FQ37250408-C1F642BF-B9D7-4CEC-9A2A-2AAE6D61E6C3Q37427083-1AA1FFBD-CE8D-4984-A073-8D760609763AQ37483119-AF379CE1-2E40-489C-85B8-A8ABD8967D7BQ38727651-5B1FD0F0-5519-40E4-AB1A-30FAF31AFC6CQ38959910-59BB3608-2ADB-41B5-8399-3C645B44F228Q39963390-8667F86B-0CCC-44F1-B75C-C6C6C837CE37Q42250957-299BFAD2-9E82-4D94-A599-5166E91E5893Q42261630-84700E55-CEC2-4286-95FD-4B8F519B87CD
P2860
Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Peroxisome proliferator-activa ...... tiation, and tissue remodeling
@nl
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@ast
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@en
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@en-gb
type
label
Peroxisome proliferator-activa ...... tiation, and tissue remodeling
@nl
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@ast
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@en
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@en-gb
prefLabel
Peroxisome proliferator-activa ...... tiation, and tissue remodeling
@nl
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@ast
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@en
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@en-gb
P2860
P921
P3181
P356
P1476
Peroxisome proliferator-activa ...... iation, and tissue remodeling.
@en
P2093
Carolyn M Komar
P2860
P2888
P3181
P356
10.1186/1477-7827-3-41
P407
P577
2005-08-30T00:00:00Z
P5875
P6179
1030547477